Japan health news

Daikin Industries announced that they demonstrated the decomposition of new influenza virus (H1N1) by 100%, and the removal of the air cleaning technology of this company that was called "Streamer discharge" on the 15th by a joint research with the Vietnamese national hygiene epidemiological study place. The demonstration of 100% decomposition is the first in the world and Iu. It is announced that it was demonstrated that the technology of the electrolysis water of this company that uses it for the air cleaner etc. decreased the number of this viruses by 99% or more over a new influenza as for Sanyo Electric in August. The streamer discharge is a technology that decomposes the virus and pollen, etc. by generating the electron with strong oxidative decomposition power. In the experiment, the cell that inoculated a new influenza virus was put on the provision that reproduced the inside of the air cleaner and the streamer discharge was continued for four hours. As a result, the virus is a confirmation lingua as the cell is normality as for the extinction lingua. Daikin is announcing that they demonstrated the decomposition of this technology of avian influenza virus (H5N1) by 100% in May. The streamer discharge technology is developed in 04, and has been installed in the air cleaner and the air conditioner etc. of this company. The technology that decomposes a new influenza virus by 100% is installed in three models such as the humidifying air cleaners put on the market on September 11 in the amount of the electrical discharge by 1.5 times since conventional. Source: Http://headlines.yahoo.co.jp/hl?a=20090915-00000068-mai-bus_all

Fuji Photo Film Co., Ltd. developed the technology that increased the sensibility to 100 times that of the current state by the simple test that examined the presence of the infection of the influenza. Plan to put chip and automatic judgement provision for high virulent bird flu (H5N1) virus inspection on the market in 2011. When it will be possible to correspond to a new influenza for a certain period including the case where it mutates to the high virulent after the purchase of the sample, it is Iu.

The simple test is a mechanism that appears by the chemical reaction if the specimen taken from subject's nose and throat is taken in the chip that paints solution, and there is a virus a thick line and is informed of. This company was able to judge tens of thousands of solutions by applying the photographic film technology for one million virus populations that were original developments, and conventional lower limit. The experiment with the H5N1 virus and the confirmation lingua.

(10:00)
http://www.nikkei.co.jp/news/sangyo/20090910AT1D0904D09092009.html

Japan is good country!
http://japan-power.net/
PLEASE come here!

  and the indemnity of the drug manufacturer when lawsuits of the import vaccine of a new influenza due to the side reaction damage occur. It corresponds according to Ministry of Health, Labour and Welfare by receiving the request of the drug manufacturer of the discharge concerning the side reaction as the condition of the vaccine sales. The development of legal systems is necessary to connect such an agreement with the drug manufacturer, and the legislation preparation for the extraordinary Diet session submission will become full-scale in the government in the future. 【 Kenji Shimizu ]

The vaccination subject in the fiscal year that Ministry of Health, Labour and Welfare assumes is about 54 million people. As for the vaccines that can be produced domestically, the deficiency is scheduled to be covered by the import in 30 million the greatest people when one person is assumed to be inoculation twice.

Two companies (Glaxo SmithKline of the drug manufacturer major (Britain) and Novartis (Switzerland)) and it negotiates with the import. It is requested that the discharge be included in the agreement for which country, and according to Ministry of Health, Labour and Welfare, in both companies, the pledge is a difficult situation and Iu as long as it doesn't agree.

There is salvation system that a constant forehead is paid from the contribution of the drug manufacturer for the side reaction of the medicine regardless of the presence of drug manufacturer and doctors' faults in case of Japan. However, it is also possible that the aggrieved party causes the damages suit with the ingluvies food. When lawsuits come one after another in each country, the drug manufacturer is requesting the discharge because there is a risk that management is pressed.

However, the country's connecting the agreement that doesn't cap the amount has the constraint on Public Finance Law, and the Ministry of Health, Labour and Welfare medicine food bureau assumes, "The law that becomes the rationale of the spending is necessary". The government starts the work of the stuff for the extraordinary Diet session.

There is a system to the drug manufacturer etc. that cannot file suit in the United States etc. according to Ministry of Health, Labour and Welfare when the aggrieved party receives a public compensation. The introduction in Japan is not easy though a new such case discharge is unnecessary relate to the right to receive the litigation secured in the constitution.

 - Language new influenza vaccine

Adjuvant of the nonuse enters in Japan for the vaccine that Japan is discussing the import, and the technology of the cell culture that has not been established in Japan is used. Inoculation starts in the end of December through the approval of the pharmaceutical Affiars Law if it is early. The home manufacture is manufactured by the method of using the egg similar to for conventional seasonality, and is an outlook of the inoculation start in the end of October.


http://mainichi.jp/select/biz/news/20090921k0000m040118000c.html

Japan is good country!
http://japan-power.net/
PLEASE come here!